Prostaglandin D Synthase (Lipocalin-type) Human ELISA

Regulatery Status: RUO
Type: Sandwich ELISA, HRP-labelled antibody
Other Names Status: BTP, Prostaglandin-H2 D-isomerase, Lipocalin-Type Prostaglandin D Synthase, Prostaglandin-H2 D-isomerase, EC=5.3.99.2, Lipocalin-type prostaglandin-D synthase, Glutathione-independent PGD synthetase, Prostaglandin-D2 synthase, PGD2 synthase, PGDS2, PGDS, Beta-trace protein, Cerebrin-28, PTGDS, PDS
Species: Human
Catalog No Size
Product Catalog No: RD191113100R Pack Size: 96 wells (1 kit)

Pack Size:
Pack Size:
Pack Size:
Pack Size:

Category:
Product Features

Lipocalin – type Prostaglandin D synthase (Beta – Trace Protein, BTP) catalyzes the conversion of PGH2 to PGD2, a prostaglandin involved in smooth muscle contraction/relaxation and a potent inhibitor of platelet aggregation. Involved in a variety of CNS functions, such as sedation, NREM (non rapid eye movement) sleep and PGE2-induced allodynia, and may have an anti-apoptotic role in oligodendrocytes. Binds small non-substrate lipophilic molecules, including biliverdin, bilirubin, retinal, retinoic acid and thyroid hormone, and may act as a scavenger for harmful hydrophopic molecules and as a secretory retinoid and thyroid hormone transporter. Possibly involved in development and maintenance of the blood-brain, blood-retina, blood-aqueous humor and blood-testis barrier. It is likely to play important roles in both maturation and maintenance of the central nervous system and male reproductive system.It has been proposed that the urinary and serum levels may provide a sensitive indicator of renal damage in diabetes mellitus and hypertension. Elevated levels in the coronary circulation may also be associated with angina. Changes in charge and molecular weight microheterogeneity, due to modification of the N-linked oligosaccharides, may be associated with neurodegenerative disease and multiple sclerosis. Detected in meningioma but not in other brain tumors and may be considered a specific cell marker for meningioma.

Features

  • European Union and rest of the world: for research use only.
  • The total assay time is less than 3 hours
  • The kit measures Beta-trace Protein in serum and plasma (EDTA, citrate, heparin).
  • Assay format is 96 wells.
  • Quality Controls are human serum based. No animal sera are used.
  • Standard is purified native protein based.
  • Components of the kit are provided ready to use or concentrated.

Research topic

Neural tissue markers, Renal disease

Technical Sheet / Info

Type

Sandwich ELISA, HRP-labelled antibody

Applications

Serum, Urine, Cerebrospinal fluid, Plasma

Sample Requirements

100 μl/well

Storage/Expiration

Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

1–40 ng/ml

Limit of Detection

0.5 ng/ml

Intra-assay (Within-Run)

n = 8; CV = 4.1%

Inter-assay (Run-to-Run)

n = 6; CV = 4.2%

Spiking Recovery

92,10%

Dilutation Linearity

93,10%

Crossreactivity

bovine         Non-detectable
cat            Non-detectable
dog            Non-detectable
goat           Non-detectable
hamster        Non-detectable
horse          Non-detectable
mouse          Non-detectable
pig            Non-detectable
rabbit         Non-detectable
rat            Non-detectable
sheep          Non-detectable
chicken        Not tested
human          Yes
monkey         Yes (recommended dilution 1:50)
Order Enquiry

Order Enquiry Form

References

– Bellei E, Monari E, Bergamini S, Cuoghi A, Tomasi A, Guerzoni S, Ciccarese M, Pini LA. Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache. J Headache Pain. 2015;16:559

– Schlatzer D, Maahs DM, Chance MR, Dazard JE, Li X, Hazlett F, Rewers M, Snell-Bergeon JK. Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes. Diabetes Care. 2012 Mar;35 (3):549-55

– Smith EM, Jorgensen AL, Midgley A, Oni L, Goilav B, Putterman C, Wahezi D, Rubinstein T, Ekdawy D, Corkhill R, Jones CA, Marks SD, Newland P, Pilkington C, Tullus K, Beresford MW. International validation of a urinary biomarker panel for identification of active lupus nephritis in children. Pediatr Nephrol. 2016 Sep 3;

Enquiry